Read the full article, here.
Mission Bio has launched the Tapestri Single-cell Multi-omics Solution – a comprehensive single-cell multi-omics platform. With a new instrument, single-cell multi-omics reagent kits, TotalSeq-D antibody content from BioLegend, and visualisation software, the package provides layered insight into multiple analytes across all blood cancers, reducing drug development time and cost by at least half. The company has parterned with BioLegend, provider of antibodies and reagents, to develop antibody panels for single-cell protein detection with the new device.
Related Posts
April 18, 2024
PeopleReign: An AI-first System of Intel…
We are thrilled to announce our recent investment in PeopleReign, a cutting-edge SaaS…
August 16, 2023
Accern Recognized in Gartner(R) 2023 Hyp…
Read the full article, here. Today, Accern, a leading provider of no-code Generative…
July 31, 2023
Dynatrace Acquires Cloud-native Debuggin…
Read the full article, here. Observability and security platform Dynatrace …